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were not significantly different between normal and isch-
aemic X-ECG groups. In addition RHI and AIx were simi-
lar between low risk as compared with intermediate-to-high 
risk, based on risk algorithms (RHI: 1.98 (0.67) vs 1.94 
(0.78); AIx: 0.0 (21) vs 5.0 (25); p = NS), or CCS and CTA 
(RHI: 1.99 (0.58) vs 1.89 (0.82); AIx: − 2.0 (24) vs 4.0 (25); 
p = NS). Finally, RHI and AIx failed to predict revascu-
larisation (RHI: OR 1.42, CI 0.65–3.1; AIx: OR 1.02, CI 
0.98–1.05).
Conclusions PAT cannot detect a low risk of CAD, possibly 
because RHI and AIx versus X-ECG, CCS and CTA repre-
sent independent processes.
Keywords Coronary artery disease ·  
Peripheral vascular function · Noninvasive testing
Introduction
Chest pain is a common symptom that may be caused by 
obstructive coronary artery disease (CAD) and requires 
risk stratification to assess the probability of CAD [1]. 
Risk algorithms have been developed based on combina-
tions of risk factors [2, 3]. However, these models tend to 
overestimate the prevalence of CAD [4], and are based on 
population calculations rather than a direct assessment of 
the atherosclerotic process within an individual. Diagnos-
tic testing with exercise electrocardiography (X-ECG) is 
considered to be highly discriminative [5], however is often 
inconclusive. Alternative tests using pharmacological stress 
are usually not immediately available. Computed tomogra-
phy (CT) is expanding in the workup [1], using coronary 
calcium scoring (CCS) [6] and computed tomographic angi-
ography (CTA) [7]. However, there are associated disadvan-
tages such as costs, radiation exposure and administration 
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Background Endothelial dysfunction precedes coronary ar-
tery disease (CAD) and can be measured by peripheral arte-
rial tonometry (PAT). We examined the applicability of PAT 
to detect a low risk of CAD in a chest pain clinic.
Methods In 93 patients, PAT was performed resulting in 
reactive hyperaemia (RHI) and augmentation (AIx) indi-
ces. Patients were risk classified according to HeartScore, 
Diamond and Forrester pretest probability (DF), exercise 
testing (X-ECG), and computed tomography calcium scor-
ing (CCS) and angiography (CTA). Correlations, risk group 
differences and prediction of revascularisation within 1 year 
were calculated.
Results RHI correlated with HeartScore (r = − 0.21, 
p = 0.05), AIx with DF (r = 0.26, p = 0.01). However, both 
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of contrast agent [8]. Therefore, a better discrimination of 
patients at low risk of clinically relevant CAD will facilitate 
more efficient use of subsequent diagnostics.
Endothelial dysfunction precedes and contributes to the 
atherosclerotic disease process. Peripheral arterial tonom-
etry (PAT) has emerged as an easy, noninvasive test to study 
endothelial function at the fingertip [9, 10]. From one sin-
gle PAT measurement both the reactive hyperaemia index 
(RHI), indicating endothelium-dependent vasodilation [11], 
and the augmentation index (AIx), indicating arterial stiff-
ness [12], can be derived. RHI and AIx have shown to be 
altered in the presence of CAD [12–15], and can be used 
in CAD risk stratification [16]. However, although PAT 
appears promising in research settings, validation in the 
clinical setting beside conventional measures has only been 
limited [11]. Therefore, the objective of this cross-sectional 
study was to assess the applicability of PAT to detect low 
risk of clinically relevant CAD in unselected patients visit-
ing a rapid-access outpatient chest pain clinic.
Methods
Study population
From September 2009 to February 2010, 93 consecutive 
patients with new onset stable chest pain without evidence 
of ongoing ischaemia and no prior history of CAD gave 
written consent to undergo finger plethysmography to mea-
sure PAT at the same time as their chest pain evaluation, 
after study approval by the Medical Ethics Committee. The 
sample size was comparable with previous PAT validation 
studies [11, 12, 16], and sufficiently large to observe dis-
criminating tendencies [17]. There were no exclusion cri-
teria. All patients were scheduled to undergo conventional 
diagnostics. Based on cut-off values of these diagnostics, 
patients at low risk of clinically relevant CAD were identi-
fied. This was verified by evaluating revascularised patients 
by percutaneous coronary intervention (PCI) or coronary 
artery bypass grafting (CABG) for up to 1 year.
Risk profiling
Cardiovascular risk factors were summarised using the 
HeartScore risk algorithm [3] to assess the risk of 10-year 
mortality of CAD and the Diamond and Forrester model 
(DF) [2, 4] to assess the pretest probability of CAD.
Exercise electrocardiography
X-ECG was performed by standardised protocol [5]. A non-
diagnostic result was defined as discontinuation without 
evidence of myocardial ischaemia before reaching 85 % of 
the target heart rate. Results were described as being non-
ischaemic, inconclusive or ischaemic. Only non-ischaemic 
and ischaemic groups were taken into comparative anal.
Cardiac computed tomography
A non-enhanced CT scan was performed to assess the 
amount of coronary calcium, followed by a contrast-
enhanced scan to assess plaque burden and presence of 
stenotic CAD. Image acquisition was conducted using a 
128-slice dual-source CT (Siemens Flash, Forchheim, Ger-
many). Coronary arteries were quantitatively evaluated per 
coronary segment for presence of atherosclerotic plaque and 
> 50 % stenosis [7]. CCS and total number of plaques and 
stenoses per patient were included in the analysis.
Peripheral arterial tonometry
The PAT response was measured with the EndoPAT 2000 
device (Itamar Medical Ltd., Caesarea, Israel), according to 
a standardised protocol allowing simultaneous determina-
tion of both RHI and AIx. An index of pulse wave amplitude 
at rest and during reactive hyperaemia resulted in RHI, a 
measure of endothelium-dependent vasodilation [9–11, 13, 
16]. Augmentation of the central pulse pressure allowed 
determination of AIx, representing endothelium-dependent 
arterial stiffness [12, 18].
Statistical analysis
Summary data are presented as numbers (proportion) or 
expressed as mean ± standard deviation or median (inter-
quartile range). In case of non-normal distribution, data 
were logarithmically transformed before analysis. Correla-
tions between RHI, AIx and conventional diagnostics were 
analysed using Pearson’s correlation coefficient. Differ-
ences between two groups were assessed by t-testing. The 
predictive value of RHI and AIx for revascularisation was 
analysed using logistic regression and described as odds 
ratio (OR) with corresponding 95 % confidence interval 
(CI). Two-tailed p < 0.05 was considered significant.
Results
Conventional diagnostic characteristics
Overall, patients were middle aged with equal distribution 
between genders (Table 1). None had a history of CAD, but 
cardiovascular risk factors were abundant and three quarters 
used cardiovascular medication. In all, conventional diag-
nostics besides PAT were performed to examine clinically 
relevant CAD (Table 2). This allowed us to examine corre-
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Digital pulse arterial tonometry testing
With regard to risk algorithms, RHI correlated weakly with 
HeartScore (r = − 0.21, p = 0.05, Fig. 1a), whereas AIx did 
not (r = 0.15, p = NS, Fig. 1b). Surprisingly, RHI did not 
correlate with DF (r = 0.05, p = NS, Fig. 1c), whereas AIx 
did modestly (r = 0.26, p < 0.05, Fig. 1d). With regard to CT 
parameters, no significant correlations between RHI and 
CCS (r = − 0.09, p = NS), plaque (r = − 0.09, p = NS, Fig. 1e) 
or stenosis (r = − 0.08, p = NS) were found. Also no signifi-
cant associations between AIx and CCS (r = 0.06, p = NS), 
plaque (r = 0.11, p = NS, Fig. 1f) or stenosis (r = 0.03, p = NS) 
were observed.
To analyse low risk of clinically relevant CAD more spe-
cifically, patients were divided into low or intermediate-to-
high risk groups based on the outcomes of risk scores, X-ECG 
and CT. According to the risk algorithms, patients at low 
risk (n = 18; defined as low risk of both DF and HeartScore 
outcomes) showed similar RHI and AIx values as compared 
with intermediate-to-high risk (n = 72; defined as intermedi-
ate-to-high risk of DF or HeartScore outcome), respectively 
(RHI: 1.98 (0.67) vs 1.94 (0.78); AIx: 0.00 (21) vs 5.0 (25); 
all p = NS; Fig. 2a, b). According to X-ECG results, low risk 
(n = 43; defined as a negative X-ECG outcome) also did not 
significantly differ from high risk (n = 7; defined as a posi-
tive outcome), respectively (RHI: 1.97 (0.72) vs 1.58 (0.61); 
AIx: − 0.50 (19) vs 8.0 (29); all p = NS). According to CT 
outcomes, low risk (n = 20; defined as absence of calcium, 
plaque and stenosis) resembled intermediate-to-high risk 
(n = 68; defined as presence of calcium, plaque or stenosis) 
(RHI: 1.99 (0.58) vs 1.89 (0.82); AIx: − 2.0 (24) vs 4.0 (25); 
all p = NS; Fig. 2c, d).
Finally, both RHI and AIx could not predict revasculari-
sation within 1 year (RHI: OR 1.42, CI 0.65–3.1; AIx: OR 
1.02, CI 0.98–1.05). Although RHI was lower in the revas-
cularised group, this was not significantly different (revas-
cularisation + (n = 11) vs revascularisation − (n = 79): 1.94 
(1.06) vs 1.96 (0.70), p = NS; Fig. 3a). Also AIx showed a 
tendency towards an altered response in the revascularised 
group, however again not statistically significant (revas-
cularisation + (n = 11) vs revascularisation − (n = 81): 4.0 
(27) vs 2.0 (23), p = NS; Fig. 3b). This is in contrast to 
conventional diagnostics: the revascularised group (n = 7) 
showed significantly more ischaemic X-ECG outcomes 
than the non-revascularised group (n = 46) (0.71 ± 0.18 vs 
0.09 ± 0.04; p < 0.01); CCS showed a modest prediction 
(OR 1.01, CI 1.00–1.03), whereas CTA-assessed plaque 
(OR 1.11, CI 1.05–1.17) and stenosis (OR 2.8, CI 1.60–4.8) 
showed strong predictions of revascularisation.
lations between PAT and conventional diagnostics, as well 
as sub-group analysis for these outcomes and prediction of 
revascularisation within 1 year.
Table 1 Patient characteristics
Demographics
Age (years) 56 ± 11
Women 40 (43 %)
Risk factors
Nicotine abuse 23 (25 %)
Hypertension 56 (60 %)
Diabetes mellitus 20 (22 %)
Dyslipidaemia 56 (60 %)
Body mass index (kg/m2) 28 ± 5
Family history of cardiovascular disease 44 (47 %)
History of vascular disease 9 (10 %)
Cardiovascular medication use 70 (75 %)
Revascularisation
PCI 10 (11 %)
CABG 2 (2 %)
PCI percutaneous coronary intervention, CABG coronary artery 
bypass grafting.
Table 2 Diagnostic characteristics
Risk scores
HeartScore low-intermediate risk < 5 % 50 (55 %)
HeartScore high risk ≥ 5 % 41 (45 %)
Median HeartScore 4 (6)
DF low pretest probability < 30 % 24 (26 %)
DF intermediate pretest probability 30–70 % 38 (41 %)
DF high pretest probability > 70 % 31 (33 %)
Median DF pretest probability 55 (51)
X-ECG
X-ECG 85 (91 %)
Inconclusive 32 (38 %)
Non-ischaemic 44 (52 %)
Ischaemic 9 (11 %)
CT
CCS 92 (99 %)
Median CCS 6.1 (94)
CTA 91 (98 %)
Median plaques 6.0 (14)
Median stenosis 0 (1)
PAT
RHI 90 (97 %)
Median RHI 1.95 (0.76)
AIx 92 (99 %)
Median Aix 3.0 (23)
DF Diamond and Forrester model, X-ECG exercise 
electrocardiography, CT computed tomography, CCS coronary 
calcium scoring, CTA computed tomography angiography, PAT 
peripheral arterial tonometry, RHI reactive hyperaemia index, AIx 
augmentation index.
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low risk based on conventional diagnostics showed non-dis-
criminative RHI and AIx outcomes. (iv) Finally, both RHI 
and AIx failed to predict revascularisation within 1 year.
Clinical applicability of PAT
(i) We confirmed the modest relation of RHI with traditional 
risk factors, as reported previously [13]. AIx showed a weak 
Discussion
The present study examined the applicability of PAT-
derived RHI and AIx to identify patients at low risk of clini-
cally relevant CAD. The most important findings were (i) 
that although RHI and AIx correlated weakly with CAD 
risk estimates, (ii) both RHI and AIx were not related with 
X-ECG or CT-imaged parameters. (iii) Most importantly, 
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Fig. 1 Correlation graphs of 
reactive hyperaemia index (RHI) 
(panels a, c, e) and augmenta-
tion index (AIx) (panels b, d, f) 
with HeartScore (panels a, b), 
Diamond and Forrester pretest 
probability (DF) (panels c, d) 
and total amount of plaque as-
sessed by computed tomographic 
angiography (CTA) (panels e, f). 
Regression equation and R2 cor-
relation coefficient are depicted 
per panel. Significant associations 
were observed between RHI and 
HeartScore as well as between 
AIx and DF, *P ≤ 0.05
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present in revascularised patients of the present study 
whereas RHI was non-discriminative, making an indepen-
dent relation likely. In addition, RHI and AIx did not sig-
nificantly correlate with CCS, in contrast to a prior study 
of selected patients [19]. Han et al. [20] also showed no 
association between coronary endothelial dysfunction and 
calcification, reflecting that both can represent separate dis-
ease stages. In addition, brachial AIx was not independently 
associated with CCS [21], supporting our results. Indeed, 
correlation with the pretest probability of CAD. Patvard-
han et al. [12] reported a strong association between AIx 
and age, most likely the basis for this correlation. (ii) No 
significant differences in either RHI or AIx were observed 
based on X-ECG outcome. This is remarkable since X-ECG 
is considered to be highly discriminative in patients at risk 
of obstructive CAD [5], and also RHI has shown to be able 
to discriminate between presence or absence of CAD [11]. 
Indeed, ischaemic X-ECG outcomes were more frequently 
Fig. 3 Differences of reactive 
hyperaemia index (RHI) (panel 
a) and augmentation index 
(AIx) (panel b) between patients 
with and without revascu-
larisation up to 1 year after PAT 
measurement. Horizontal bars 
depict the median value. No 
significant differences between 
the groups were observed. 
Revasc − no revascularisation; 
Revasc + revascularisation
 
Fig. 2 Differences of reactive 
hyperaemia index (RHI) (panels 
a, c) and augmentation index 
(AIx) (panels b, d) between 
patients at low and intermedi-
ate-to-high risk of clinically 
relevant CAD based on the 
combined outcome of risk 
scores (a, b), and CCS and CTA 
assessed plaque and stenosis (c, 
d). Horizontal bars depict the 
median value. No significant 
differences between the groups 
were observed. RF risk factors, 
X-ECG exercise ECG, CT com-
puted tomography, low low risk, 
int-hi intermediate-to-high risk
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other vascular function tests have previously indicated 
that endothelial dysfunction may represent an independent 
response in the progression of CAD, whereas a relation with 
the development of atherosclerosis exists [22–26]. RHI and 
AIx were not significantly associated with CTA-imaged 
plaque or stenosis. This is contrary to previous studies with 
imaged CAD describing specific subgroups with proven 
CAD [11, 12], diabetes [14], or women [15] although the 
presence of CAD was not verified with CTA in any of them. 
(iii) Also, RHI and AIx were not able to differentiate low 
risk of clinically relevant CAD, in contrast to results in 
selected populations [11, 12, 16], complicating comparison 
with our unselected population. (iv) Finally, RHI and AIx 
failed to predict revascularisation within 1 year, contrary to 
Rubinshtein, who showed that RHI independently predicted 
revascularisation [27]. Also radial AIx predicted revascular-
isation [28], although for digital AIx no such studies exist to 
our knowledge. However, again selected patients were eval-
uated with adverse events occurring at long-term follow-up, 
which is difficult to compare with our 1-year evaluation. 
Indeed, patient selection may strongly influence outcome 
because specific risk factors have additional effects on the 
measurement itself besides on the CAD process, as high-
lighted by the study of Gargiulo [14].
Conclusions
In spite of the pathophysiological basis of endothelial dys-
function in CAD and the promising results with PAT in 
selected populations under controlled conditions, we found 
no evidence to support PAT as a diagnostic tool to detect low 
risk of clinically relevant CAD in an unselected outpatient 
population.
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